Kindred Biosciences, Inc. KIN
We take great care to ensure that the data presented and summarized in this overview for Kindred Biosciences, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in KIN
Top Purchases
Top Sells
About KIN
Insider Transactions at KIN
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 27
2021
|
Park West Asset Management LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
6,000,002
-100.0%
|
-
|
|
Aug 27
2021
|
Raymond Townsend Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
24,928
-100.0%
|
$224,352
$9.25 P/Share
|
|
Aug 27
2021
|
Hangjun Zhan Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
64,306
-100.0%
|
$578,754
$9.25 P/Share
|
|
Aug 27
2021
|
Denise Bevers Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
145,835
-100.0%
|
$1,312,515
$9.25 P/Share
|
|
Aug 27
2021
|
Wendy Wee Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
78,613
-100.0%
|
$707,517
$9.25 P/Share
|
|
Aug 27
2021
|
Richard Chin Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
8,000
-100.0%
|
$72,000
$9.25 P/Share
|
|
Aug 27
2021
|
Richard Chin Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,709,271
-100.0%
|
$15,383,439
$9.25 P/Share
|
|
Aug 27
2021
|
Elanco Animal Health Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
45,508,938
+99.98%
|
$409,580,442
$9.25 P/Share
|
|
Aug 02
2021
|
Richard Chin Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,000
-2.54%
|
$360,000
$9.21 P/Share
|
|
Jul 22
2021
|
Richard Chin Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
320,000
-16.89%
|
-
|
|
Jul 02
2021
|
Richard Chin Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,000
-2.07%
|
$360,000
$9.18 P/Share
|
|
Jun 16
2021
|
Richard Chin Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,000
-2.03%
|
$360,000
$9.18 P/Share
|
|
Jun 04
2021
|
Park West Asset Management LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
345,383
-5.44%
|
$2,072,298
$6.95 P/Share
|
|
Jun 03
2021
|
Park West Asset Management LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
69,600
-1.09%
|
$417,600
$6.8 P/Share
|
|
Mar 17
2021
|
Denise Bevers Director |
SELL
Open market or private sale
|
Indirect |
8,396
-100.0%
|
$41,980
$5.0 P/Share
|
|
Mar 17
2021
|
Denise Bevers Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
8,396
+50.0%
|
$0
$0.32 P/Share
|
|
Feb 22
2021
|
Denise Bevers Director |
SELL
Open market or private sale
|
Indirect |
4,622
-100.0%
|
$23,110
$5.0 P/Share
|
|
Feb 22
2021
|
Denise Bevers Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,622
+50.0%
|
$0
$0.32 P/Share
|
|
Feb 19
2021
|
Denise Bevers Director |
SELL
Open market or private sale
|
Indirect |
5
-100.0%
|
$25
$5.0 P/Share
|
|
Feb 19
2021
|
Denise Bevers Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
5
+50.0%
|
$0
$0.32 P/Share
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders